39th St Luke's Lecture & 11th St Luke's Young Investigators Award
The Royal Academy of Medicine in Ireland and St Luke's Hospital invite you to the 39th St Luke's Lecture and the 11th St Luke's Young Investigators Award which take place on Wednesday 29th January 2014 from 6pm at the Royal College of Physicians in Ireland, Kildare Street.
which will be given by Prof Malcolm Kell (Consultant Surgeon, MMUH and UCD Associate Clinical Professor) at 6pm on
Professor Malcolm R Kell, MBChB, FRCS Glasg. (Gen Surg), FRCSI, MD (Consultant Surgeon, Mater Misericordiae University Hospital, Dublin and UCD Associate Clinical Professor) will deliver the 39th St. Luke’s Lecture 2014 entitled "Breast Cancer; from Halstead to Harney.”
The management of Breast cancer has changed dramatically since the early 1970s. Numerous studies have helped develop modern breast cancer surgery whereby conservative surgery is now the standard of care. Both the management of the breast and the axilla have evolved to not only achieve the best oncological outcomes but also limit patient morbidity from treatment. Breast reconstructive surgery is now routinely used to rebuild breasts after mastectomy and a range of techniques are now available to obtain the optimum results and also avoid potential problems associated with radiotherapy.
As our understanding of the pathogenesis of breast cancer has improved, we can now identify patients at risk and then offer genetic screening to high risk individuals. Once identified with a BRCA abnormality, patients can be radiologically screened and offered potential prophylactic measures to reduce the risk of developing cancer. Prophylactic mastectomy provides excellent risk reduction for high risk patients and novel tools are now available to measure patient quality of life after this prophylactic surgery.
Breast screening has been the model of cancer screening over the last 4 decades. However numerous controversies exist regarding the efficacy of mammographic screening. Recent evidence strongly supports mammographic screening when different screening studies are examined uniformly. The Irish Breastcheck program exemplifies best outcomes from screening, and data from the Irish program strongly supports breast cancer screening.
A canapés and wine reception will follow in the Graves Hall.
11th St Luke's Young Investigator Award 2014
Dr. Antoinette S Perry
Translational Epigenetics for the Early Detection of Aggressive Prostate Cancer Purpose
Dr. Britta Stordal
The EMT-Activator ZEB1 Is Unrelated To Platinum Drug Resistance In Ovarian Cancer But Predictive Of
Dr. Maria Prencipe
A New Molecular Target For Castrate-Resistant Prostate Cancer: Negative Feedback Loop
Between SRF And AR
Dr. Anne Marie Byrne
Exploiting The Protein Secretory Pathway To Identify Novel Oncoproteins Involved In Oesophageal Carcinogenesis
The Royal Academy of Medicine in Ireland will present an Honorary Fellowship to Dr. Susan E. O’Reilly, MB, FRCPC, (National Director, National Cancer Control Programme).
As seating is limited please register on the following link